Although it is commonly pointed out that TGFβ pathway components are frequently mutated in colorectal tumors, and that disruption of TGFβ signaling promotes malignant progression in experimental models of intestinal cancer [18, 20–24] our results show that cancer cells themselves can be relevant targets of TGFβ signaling. The gene discussed is TGFB1; the disease is cancer.